Mohammad Atefi
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 3
- Cytokine Signaling Pathways and Interactions 3
- Cancer Research top 5%
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 10
- Genetics top 5%
-
- Hemostasis and retained surgical items 3
-
- Electromagnetic Fields and Biological Effects 3
-
- Psychological and Temporal Perspectives Research 3
-
- Surgical Sutures and Adhesives 3
-
- Noise Effects and Management 3
Mohammad Atefi
31 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.6k
- Cancer Research 561
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 1.3k
- Genetics 200
Countries citing papers authored by Mohammad Atefi
This map shows the geographic impact of Mohammad Atefi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Atefi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Atefi more than expected).
Fields of papers citing papers by Mohammad Atefi
This network shows the impact of papers produced by Mohammad Atefi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Atefi. The network helps show where Mohammad Atefi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammad Atefi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stressbreakdown → | 2018 | 583 |
| 3 | 2017 | 42 | |
| 4 | 2016 | 82 | |
| 5 | 2015 | 2 | |
| 6 | 2014 | 285 | |
| 7 | 2014 | 17 | |
| 8 | 2014 | 85 | |
| 9 | 2014 | 28 | |
| 10 | 2014 | 66 | |
| 11 | 2013 | 23 | |
| 12 | 2013 | 31 | |
| 13 | 2013 | 15 | |
| 14 | 2012 | 61 | |
| 15 | CHARACTERISTICS OF COOL CLOT, THE INVENTED NOVEL HEMOSTATIC AGENT | 2011 | 2 |
| 16 | The Pattern of Mobile Phone Use and Prevalence of Self-Reported Symptoms in Elementary and Junior High School Students in Shiraz, Iran | 2011 | 18 |
| 17 | 2011 | 183 | |
| 18 | PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitrobreakdown → | 2009 | 1044 |
| 19 | The Effect of Radioactive Lantern Mantle Powder and Bentonite-Zeoloite Minerals on the Volume of Blood Loss, Bleeding and Clotting Time | 2009 | 2 |
| 20 | Evaluation of the Interference of the Microwave Radiation Emitted from GSM Mobile Phones on the Performance of Cell Counters | 2008 | 2 |
About Mohammad Atefi
Mohammad Atefi is a scholar working on Biophysics, Complementary and Manual Therapy and Speech and Hearing, having authored 31 papers that have together received 2.8k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (10 papers), Hemostasis and retained surgical items (3 papers), Electromagnetic Fields and Biological Effects (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Psychological and Temporal Perspectives Research (3 papers), Surgical Sutures and Adhesives (3 papers), Noise Effects and Management (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (561 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Mohammad Atefi has collaborated with scholars based in United States, Iran and Italy. Frequent co-authors include Antoni Ribas, Deborah J. Wong, Richard S. Finn, Dylan Conklin, David J. Cohen, Amrita Desai, Dennis J. Slamon, Camilla Fowst, Ondrej Kalous and Judy Dering. Their work appears in journals such as Molecular Cancer, Clinical Cancer Research, Blood Coagulation & Fibrinolysis, Cancer Research and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.